These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1136 related items for PubMed ID: 21301356

  • 1. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
    Basseri RJ, Kunkel D, Low K, Conklin JL, Pimentel M.
    J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
    [Abstract] [Full Text] [Related]

  • 2. The degree of breath methane production in IBS correlates with the severity of constipation.
    Chatterjee S, Park S, Low K, Kong Y, Pimentel M.
    Am J Gastroenterol; 2007 Apr; 102(4):837-41. PubMed ID: 17397408
    [Abstract] [Full Text] [Related]

  • 3. Characterization of episodes of irritable bowel syndrome using ecological momentary assessment.
    Weinland SR, Morris CB, Hu Y, Leserman J, Bangdiwala SI, Drossman DA.
    Am J Gastroenterol; 2011 Oct; 106(10):1813-20. PubMed ID: 21647206
    [Abstract] [Full Text] [Related]

  • 4. Episodic nature of symptoms in irritable bowel syndrome.
    Palsson OS, Baggish J, Whitehead WE.
    Am J Gastroenterol; 2014 Sep; 109(9):1450-60. PubMed ID: 24980882
    [Abstract] [Full Text] [Related]

  • 5. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
    Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD.
    Am J Gastroenterol; 2003 Nov; 98(11):2454-9. PubMed ID: 14638348
    [Abstract] [Full Text] [Related]

  • 6. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.
    Aliment Pharmacol Ther; 2005 Feb 15; 21(4):435-44. PubMed ID: 15709995
    [Abstract] [Full Text] [Related]

  • 7. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
    Dove LS, Lembo A, Randall CW, Fogel R, Andrae D, Davenport JM, McIntyre G, Almenoff JS, Covington PS.
    Gastroenterology; 2013 Aug 15; 145(2):329-38.e1. PubMed ID: 23583433
    [Abstract] [Full Text] [Related]

  • 8. Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study).
    Garrigues V, Mearin F, Badía X, Balboa A, Benavent J, Caballero A, Domínguez E, Díaz-Rubio M, Roset M, Figueras M, Cucala M, RITMO GROUP.
    Aliment Pharmacol Ther; 2007 Feb 01; 25(3):323-32. PubMed ID: 17217445
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.
    Lee KJ, Kim NY, Kwon JK, Huh KC, Lee OY, Lee JS, Choi SC, Sohn CI, Myung SJ, Park HJ, Choi MK, Bak YT, Rhee PL.
    Neurogastroenterol Motil; 2011 Dec 01; 23(12):1098-104. PubMed ID: 21920001
    [Abstract] [Full Text] [Related]

  • 10. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak.
    Zanini B, Ricci C, Bandera F, Caselani F, Magni A, Laronga AM, Lanzini A, San Felice del Benaco Study Investigators.
    Am J Gastroenterol; 2012 Jun 01; 107(6):891-9. PubMed ID: 22525306
    [Abstract] [Full Text] [Related]

  • 11. Short-term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification.
    Engsbro AL, Simren M, Bytzer P.
    Aliment Pharmacol Ther; 2012 Feb 01; 35(3):350-9. PubMed ID: 22176384
    [Abstract] [Full Text] [Related]

  • 12. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
    Ersryd A, Posserud I, Abrahamsson H, Simrén M.
    Aliment Pharmacol Ther; 2007 Sep 15; 26(6):953-61. PubMed ID: 17767480
    [Abstract] [Full Text] [Related]

  • 13. Further characterization of painful constipation (PC): clinical features over one year and comparison with IBS.
    Drossman DA, Morris C, Hu Y, Leserman J, Dalton C, Toner B, Diamante N, Bangdiwala S.
    J Clin Gastroenterol; 2008 Sep 15; 42(10):1080-8. PubMed ID: 18949838
    [Abstract] [Full Text] [Related]

  • 14. Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study.
    Tack JF, Miner PB, Fischer L, Harris MS.
    Aliment Pharmacol Ther; 2011 Oct 15; 34(8):868-77. PubMed ID: 21883322
    [Abstract] [Full Text] [Related]

  • 15. A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.
    Chang L, Ameen VZ, Dukes GE, McSorley DJ, Carter EG, Mayer EA.
    Am J Gastroenterol; 2005 Jan 15; 100(1):115-23. PubMed ID: 15654790
    [Abstract] [Full Text] [Related]

  • 16. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
    Yao X, Yang YS, Cui LH, Zhao KB, Zhang ZH, Peng LH, Guo X, Sun G, Shang J, Wang WF, Feng J, Huang Q.
    J Gastroenterol Hepatol; 2012 Apr 15; 27(4):760-5. PubMed ID: 21929652
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome.
    Tillisch K, Labus JS, Naliboff BD, Bolus R, Shetzline M, Mayer EA, Chang L.
    Am J Gastroenterol; 2005 Apr 15; 100(4):896-904. PubMed ID: 15784038
    [Abstract] [Full Text] [Related]

  • 18. Bloating and distention in irritable bowel syndrome: the role of visceral sensation.
    Agrawal A, Houghton LA, Lea R, Morris J, Reilly B, Whorwell PJ.
    Gastroenterology; 2008 Jun 15; 134(7):1882-9. PubMed ID: 18455167
    [Abstract] [Full Text] [Related]

  • 19. Evidence for pelvic floor dyssynergia in patients with irritable bowel syndrome.
    Suttor VP, Prott GM, Hansen RD, Kellow JE, Malcolm A.
    Dis Colon Rectum; 2010 Feb 15; 53(2):156-60. PubMed ID: 20087090
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Bensoussan A, Kellow JE, Bourchier SJ, Fahey P, Shim L, Malcolm A, Boyce P.
    Clin Gastroenterol Hepatol; 2015 Nov 15; 13(11):1946-54.e1. PubMed ID: 26133902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.